# Favipiravir in Hospitalized COVID-19 Patients

> **NCT04359615** · PHASE4 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 40 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Favipiravir
- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT04359615
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-20
- **Primary completion:** 2020-05-03
- **Final completion:** 2020-05-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04359615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04359615, "Favipiravir in Hospitalized COVID-19 Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04359615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*